Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.62% | 8.98% | -18.52% | 3.44% | 30.68% |
| Total Depreciation and Amortization | -3.09% | -1.15% | 1.47% | 5.59% | 10.59% |
| Total Amortization of Deferred Charges | 0.26% | -24.82% | -24.86% | -24.84% | -24.89% |
| Total Other Non-Cash Items | 110.61% | 286.12% | 320.46% | 70.88% | -61.65% |
| Change in Net Operating Assets | -311.63% | -213.04% | 392.54% | -72.92% | 46.92% |
| Cash from Operations | 3.05% | 26.19% | 24.61% | 16.77% | 20.96% |
| Capital Expenditure | -63.90% | -71.26% | 23.18% | 59.66% | 68.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.69% | -126.28% | 50.42% | 1,209.08% | 182.76% |
| Cash from Investing | -98.10% | -131.10% | 58.28% | 3,282.89% | 262.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.94% | -97.05% | -74.83% | -74.83% | 4,423.85% |
| Repurchase of Common Stock | -535.38% | -40.05% | -13.43% | -0.59% | -48.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.36% | 98.99% | 94.88% | 116.42% | 92.32% |
| Cash from Financing | -113.99% | -100.21% | -76.23% | -72.90% | 351.22% |
| Foreign Exchange rate Adjustments | 107.48% | -94.29% | 219.23% | -82.96% | -94.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.93% | -150.81% | -22.68% | 1,268.43% | 358.76% |